Posted by Michael Wonder on 13 Mar 2017
Skyrocketing drug prices key question in Trump health care reform
12 March 2017 - Amid the drive to repeal and replace Obamacare, the question remains whether President Donald Trump and the Republican-led Congress can bring down skyrocketing drug prices.
Recent controversies surrounding dramatic increases for prices of EpiPen and HIV drugs have placed pharmaceutical costs near the top of American public policy debates.
Trump has railed against the industry and vowed to bring prices down.
But experts say Trump will struggle to realise that goal due to a system that involves a complex web of players and incentives.
